Matt Rizner
Matt Rizner is a Vice President with J.P. Morgan Private Bank who helps families and non-profits establish and meet their goals. This starts with building a deep relationship to understand not only the financial goals, but also the impact and legacy his clients want to leave. The advice covers investment and cash management, customized borrowing, complex trust and estate structuring, and charitable giving.
Outside of his day job, Matt spends his time with Inspirica, a Stamford-based non-profit to help fight homelessness, as well as at Temple Sinai with family and friends. Matt is also an active member of BioCT and CEF to support and expand entrepreneurship industry across Connecticut and Westchester.
Matt holds a bachelor’s degree from the University of Vermont and an M.B.A. from Tulane University. Born and raised in Vermont, he resides in Stamford with his wife, two children, and their mini-labradoodle.

Matt Rizner
Vice President, J.P. Morgan Private Bank



















John has spent over 30 years at Pfizer in various areas of manufacturing bulk active pharmaceutical ingredients and Quality Assurance organization for clinical manufacturing activities in Groton, CT. In his current role at Pfizer John is primarily involved with qualifying solid dose manufacturing equipment and validating related computer systems. This also entails quality investigations, change management and regulatory compliance. In 2016, John was part of a team that built Pfizer’s first continuous tablet manufacturing facility which won an ISPE (International Society of Pharmaceutical Engineers) Facility of the Year Award. In 2018, John helped launch Pfizer’s first commercial product (Daurismo) using the new continuous manufacturing technology. John holds a BS in chemical engineering from Worcester Polytechnic Institute, an MBA in Operations Management from Rensselaer Polytechnic Institute, and is a Registered Professional Engineer in the State of Connecticut.
David leads a small team of technologists exploring innovative technologies to support Life Sciences R&D at Bayer. Over the last 20 years at Bayer, David has focused on leading organizational change, digital transformation, innovation methodologies, project management and GxP validation. Most recently, David was the IT lead for the Wearable POC for Bayer’s Digital Device platform, which provided a platform and business processes to enable digital monitoring and interactions with patients using biosensors, wearables, and mobile applications. David earned an MBA from Northeastern University and has worked in IT as a Developer, Project Manager and Manager across industries including Financial Services, IT Consulting and Life Sciences R&D.